Literature DB >> 9349762

Sequential endoscopic/laparoscopic management of cholelithiasis and choledocholithiasis in children who have sickle cell disease.

A H Al-Salem1, H Nourallah.   

Abstract

BACKGROUND/
PURPOSE: Cholelithiasis and choledocholithiasis are common complications of sickle cell disease (SCD). With the recent advances in laparoscopic cholecystectomy (LC), which has been used successfully for the management of cholelithiasis in children who have SCD, exclusion of choledocholithiasis before LC is of great importance.
METHODS: Eighteen children who had SCD, cholelithiasis, and choledocholithiasis were treated at our hospital. Seven were treated with open cholecystectomy (OC) and common bile duct (CBD) exploration, and two were treated with transduodenal sphincteroplasty. The remaining 11 patients underwent endoscopic retrograde cholangiopancreatography (ERCP), sphincterotomy, and stone extraction followed by laparoscopic cholecystectomy (LC).
RESULTS: A dilated CBD noted on ultrasound, elevated alkaline phosphatase, elevated total bilirubin of more than 5 mg/dL, history of pancreatitis, either singly or in combination, should raise suspicion of choledocholithiasis, and these patients together with those who have choledocholithiasis detected on ultrasound should undergo ERCP to confirm and extract the stones before LC.
CONCLUSION: This sequential approach of endoscopic sphincterotomy and stone extraction followed by LC is a safe and effective approach for the management of cholelithiasis and choledocholithiasis in children who have SCD.

Entities:  

Mesh:

Year:  1997        PMID: 9349762     DOI: 10.1016/s0022-3468(97)90555-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Results and complications of laparoscopic cholecystectomy in childhood.

Authors:  C Esposito; M A Gonzalez Sabin; F Corcione; R Sacco; G Esposito; A Settimi
Journal:  Surg Endosc       Date:  2001-05-02       Impact factor: 4.584

2.  Diagnostic and therapeutic ERCP in the pediatric age group.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Pediatr Surg Int       Date:  2006-12-06       Impact factor: 1.827

3.  Role of ERCP in the era of laparoscopic cholecystectomy for the evaluation of choledocholithiasis in sickle cell anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

4.  Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed Al-Salem
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

5.  Lessons learned from the first 109 laparoscopic cholecystectomies performed in a single pediatric surgery center.

Authors:  Ciro Esposito; Francesca Alicchio; Ida Giurin; Flavio Perricone; Giuseppe Ascione; Alessandro Settimi
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

6.  Laparoscopic splenectomy and/or cholecystectomy for children with sickle cell disease.

Authors:  Abdulla Alwabari; Lalit Parida; Ahmed Hassan Al-Salem
Journal:  Pediatr Surg Int       Date:  2009-04-16       Impact factor: 1.827

7.  Perioperative management in children with sickle cell disease undergoing laparoscopic surgery.

Authors:  Claudio Sandoval; Gustavo Stringel; M Fevzi Ozkaynak; Oya Tugal; Somasundaram Jayabose
Journal:  JSLS       Date:  2002 Jan-Mar       Impact factor: 2.172

8.  [Sickle cell disease and biliary lithiasis - about two observations in Lubumbashi (DR Congo)].

Authors:  Léon Kabamba Ngombe; Pascal Kimba Mukanya; Gray Wakamb Kanteng; Augustin Mutombo Mulangu; Oscar Luboya Numbi
Journal:  Pan Afr Med J       Date:  2015-07-20

9.  ERCP in Patients With Sickle Cell Disease: Diagnostic and Therapeutic Dilemmas.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-03-20

Review 10.  Hepatobiliary Manifestations of Sickle Cell Anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.